AstraZeneca Q3 Profit Jumps 77% to $2.53 Billion
British-Swedish pharma giant AstraZeneca reports blockbuster Q3 results with profits surging 77% to $2.53 billion, driven by robust cancer drug sales and strategic US market expansion.
Category : Search result: pharmaceutical chemistry
Piramal Pharma Bets on US Biopharma Funding Revival
Piramal Pharma anticipates significant growth as US biopharma funding shows recovery signs, with CDMO business poised for major expansion.
IIT Madras & Ohio State Create Chemistry-Mimicking AI
Groundbreaking AI framework from IIT Madras and Ohio State University could revolutionize chemical research by predicting molecular behavior with unprecedented accuracy.
DRI Busts Illegal Alprazolam Factory in Gujarat
In a significant crackdown, the Directorate of Revenue Intelligence dismantled a sophisticated drug factory in Gujarat's Valsad district, seizing massive quantities of Alprazolam worth crores and arresting key operatives.
Novo Nordisk Profit Drops 27%, Cuts 9,000 Jobs
Danish pharmaceutical giant Novo Nordisk faces turbulent times as Q3 profits drop 27% despite Ozempic's success. The company announces massive restructuring with 9,000 job cuts worldwide. Get the inside story on what's happening behind the scenes.
Solara Pharma Q2 Loss: ₹10 Crore Amid Challenges
Solara Active Pharma Sciences faces challenging quarter with ₹10 crore net loss despite revenue growth. Discover the operational challenges and management's recovery strategy.
Sun Pharma Q2 Profit Rises 2.5% to ₹3,118 Crore
India's pharmaceutical giant Sun Pharma reports steady Q2 growth with 9% revenue increase while navigating US market challenges. Key insights from their latest earnings report.
AgentForce AI Revolutionizes Life Sciences Engagement in India
Discover how AgentForce's AI-powered platform is reshaping customer engagement in India's life sciences sector, eliminating burnout while boosting productivity by 40%.
Baddi Pharma Raid: Sub-Standard Medicines Shipped to Rajasthan
Himachal Pradesh drug control authorities raid Baddi pharmaceutical facility after Rajasthan complaints reveal distribution of sub-standard medicines across seven districts, raising serious public health concerns.
Bharat Biotech enters cell & gene therapy with Nucelion
Indian vaccine maker Bharat Biotech expands into high-growth CRDMO space with new subsidiary Nucelion Therapeutics, focusing on cutting-edge cell and gene therapies for cancer and rare diseases.
Indian Exports to US Crash 37.5% Amid Trump Tariffs
Indian exports to the US plummeted 37.5% amid 50% Trump tariffs, with smartphones and pharmaceuticals taking the biggest hit. Get the complete trade impact analysis.
US Tariffs Crush Indian Exports: 37.5% Plunge
GTRI report reveals devastating 37.5% decline in India's key exports to US, with smartphones, pharmaceuticals, and gems taking the hardest hit from American tariff policies.
FDA Recalls Blood Pressure Meds Over Cancer Risk
Multiple blood pressure medications recalled after FDA detects potential cancer-causing impurities. Find out if your medication is affected and what steps to take immediately.
Health Biotech Expands Global Presence at CPhI Frankfurt
Indian biopharmaceutical leader Health Biotech Limited makes waves at CPhI Frankfurt 2025, showcasing innovative products and forging international partnerships to strengthen its global market position.
Niner Pharma Expands R&D with 125 New Peptide Molecules
Chandigarh-based Niner Pharma announces massive R&D expansion with 125 novel peptide molecules targeting wellness and cosmetic innovation, positioning India as global leader in peptide research.
Cipla CEO Change: Achin Gupta Succeeds Umang Vohra
Indian pharmaceutical giant Cipla reveals strategic leadership transition with Achin Gupta succeeding Umang Vohra as Global CEO in September 2024, marking a new era for the company.
FDA Recalls 580K Blood Pressure Meds Over Cancer Risk
Major pharmaceutical recall alert: FDA discovers carcinogenic impurity in popular blood pressure medications, affecting hundreds of thousands of patients across the US. Safety concerns prompt immediate withdrawal.
Eli Lilly Ups Forecast as Zepbound Demand Soars
Pharmaceutical giant Eli Lilly raises full-year profit forecast as demand skyrockets for revolutionary weight-loss treatment Zepbound, sending shares climbing 7%.
Cipla Shares Fall 4% After Q2 Results
Cipla's stock faced significant pressure after Q2 FY2025 results revealed margin pressures despite revenue growth. Discover the key factors behind the 4% decline and what analysts are saying about the pharmaceutical giant's future prospects.
Punjab de-addiction centres sold pills in black market: ED probe
Shocking probe reveals Punjab doctor's de-addiction centres allegedly operated pill trafficking network while claiming to treat addiction. ED uncovers massive pharmaceutical diversion scheme.
Life's Seeds Found in Deep Space Ice Beyond Milky Way
Groundbreaking research reveals discovery of life's essential molecules in distant galactic ice clouds, rewriting our understanding of cosmic origins.
India Bans Fraudulent Pharma Licenses in Major Reform
India implements sweeping regulatory reforms to combat fraudulent pharmaceutical manufacturing licenses, enhancing drug safety standards for domestic and international markets including US and EU.
Eli Lilly & NVIDIA Partner for AI Drug Discovery
Pharmaceutical giant Eli Lilly partners with NVIDIA to deploy cutting-edge AI supercomputers that will accelerate drug development and transform pharmaceutical research.
Texas Sues Johnson & Johnson Over Tylenol-Autism Link
The state of Texas has filed a lawsuit against Johnson & Johnson and its spin-off Kenvue, alleging the companies failed to warn consumers about potential autism risks associated with Tylenol use during pregnancy. This legal action comes just weeks after f
Sanofi India appoints Deepak Arora as Managing Director
Sanofi India announces Deepak Arora as its new Managing Director, bringing extensive pharmaceutical experience to drive growth and innovation in the Indian healthcare market.
India probes anti-dumping of TB drugs from China, Thailand
India initiates anti-dumping investigation on tuberculosis medication imports from China and Thailand following domestic industry complaints about unfair pricing practices affecting local manufacturers.
SafeCure Services IPO: ₹60 Cr Offer Opens Oct 29
Delhi-based pharmaceutical support company SafeCure Services Ltd plans to raise up to ₹60 crore through IPO. Fresh issue of 48 lakh shares priced at ₹60-75 each. Learn key dates and details.
Punjab bans 112 substandard drugs in health safety drive
In a major healthcare move, Punjab government prohibits sale of 112 substandard drugs following quality control tests. Find out which medications are affected and what this means for public health safety.
Novartis Nears $1.7B Avidity Biosciences Acquisition
Swiss pharmaceutical giant Novartis AG is finalizing a landmark acquisition of California-based Avidity Biosciences in a deal valuing the biotech firm at over $70 per share, potentially exceeding $1.7 billion, according to exclusive reports.
NCB grills health staff in Amritsar tramadol racket
Narcotics Control Bureau investigates two Punjab Health Department employees for alleged involvement in illegal tramadol distribution network. Shocking revelations emerge during interrogation.
Page 3 of 4